Perkins Capital Management’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-125,212
| Closed | -$538K | – | 93 |
|
|
2023
Q3 | $538K | Sell |
125,212
-1,000
| -0.8% | -$4.3K | 0.53% | 52 |
|
|
2023
Q2 | $655K | Sell |
126,212
-11,000
| -8% | -$57.1K | 0.57% | 50 |
|
|
2023
Q1 | $933K | Sell |
137,212
-80,888
| -37% | -$550K | 0.88% | 42 |
|
|
2022
Q4 | $534K | Hold |
218,100
| – | – | 0.56% | 51 |
|
|
2022
Q3 | $720K | Sell |
218,100
-10,000
| -4% | -$33K | 0.81% | 40 |
|
|
2022
Q2 | $1.11M | Buy |
228,100
+53,500
| +31% | +$261K | 1.15% | 32 |
|
|
2022
Q1 | $1.32M | Hold |
174,600
| – | – | 1.08% | 37 |
|
|
2021
Q4 | $1.36M | Buy |
174,600
+5,000
| +3% | +$38.9K | 0.92% | 39 |
|
|
2021
Q3 | $1.44M | Sell |
169,600
-2,500
| -1% | -$21.3K | 0.89% | 39 |
|
|
2021
Q2 | $1.55M | Buy |
172,100
+131,500
| +324% | +$1.18M | 0.88% | 40 |
|
|
2021
Q1 | $470K | Hold |
40,600
| – | – | 0.27% | 78 |
|
|
2020
Q4 | $329K | Buy |
+40,600
| New | +$329K | 0.22% | 75 |
|